Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
C$0.11
C$0.11
C$0.02
C$0.16
C$952KN/A3.16 million shs1.31 million shs
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$0.01
C$0.01
C$0.01
C$0.02
C$1.85MN/A317,764 shs26,000 shs
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
C$0.02
-25.0%
C$0.02
C$0.02
C$0.10
C$984K1.5152,289 shs4,000 shs
PBS
Invesco Next Gen Media and Gaming ETF
$41.42
+2.0%
$42.04
$30.95
$40.10
$29.82M1.385,287 shs4,296 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
0.00%0.00%0.00%0.00%0.00%
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
0.00%0.00%0.00%0.00%0.00%
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
0.00%0.00%0.00%0.00%0.00%
PBS
Invesco Next Gen Media and Gaming ETF
0.00%-3.46%-7.57%+0.36%+17.58%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
0.00
N/A$47.4014.42% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AC$0.01 per share8.75C$0.00 per shareN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$2.23M0.83C$0.00 per share10.00C($0.07) per share-0.15
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AC$0.00 per share55.00C($0.02) per shareN/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A-C$0.01N/AN/AN/AN/AN/AN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A-C$0.01N/AN/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/A-C$0.01N/AN/AN/AN/A-340.40%N/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/A33.44N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/AN/AN/AN/AN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
$0.250.60%N/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A
1.14
1.12
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A
0.04
0.03
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
882.79
0.03
0.17
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
iCo Therapeutics Inc. stock logo
ICO
iCo Therapeutics
N/A9.07 millionN/ANot Optionable
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
7184.98 millionN/ANot Optionable
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
665.59 millionN/ANot Optionable
PBS
Invesco Next Gen Media and Gaming ETF
N/A720,000N/ANot Optionable

PBS, MFS, PAS, and ICO Headlines

SourceHeadline
IGPT Invesco AI and Next Gen Software ETFIGPT Invesco AI and Next Gen Software ETF
seekingalpha.com - December 16 at 7:25 PM
"Barbie" Hits $1B at Box Office: Media ETFs on a Roll"Barbie" Hits $1B at Box Office: Media ETFs on a Roll
finance.yahoo.com - August 8 at 11:00 AM
Media Stocks & ETFs in Focus on "Barbenheimer"s SuccessMedia Stocks & ETFs in Focus on "Barbenheimer"s Success
finance.yahoo.com - July 24 at 4:14 PM
ETFs to Add Gains on Netflix Q2 Solid Subscriber GrowthETFs to Add Gains on Netflix Q2 Solid Subscriber Growth
finance.yahoo.com - July 20 at 3:20 PM
These 2 Invesco ETFs Offer Meta ExposureThese 2 Invesco ETFs Offer Meta Exposure
nasdaq.com - April 28 at 12:43 AM
Invesco Dynamic Media PBS Trading ReportInvesco Dynamic Media PBS Trading Report
marketwatch.com - February 21 at 2:10 PM
Invesco Dynamic Media ETF declares quarterly distribution of $0.0486Invesco Dynamic Media ETF declares quarterly distribution of $0.0486
msn.com - December 22 at 6:52 PM
Invesco Dynamic Energy Exploration & Production ETF declares quarterly distribution of $0.3119Invesco Dynamic Energy Exploration & Production ETF declares quarterly distribution of $0.3119
msn.com - December 22 at 1:51 PM
Invesco Dynamic Building & Construction ETF declares quarterly distribution of $0.0658Invesco Dynamic Building & Construction ETF declares quarterly distribution of $0.0658
msn.com - December 22 at 1:51 PM
Netflix Returns to Growth, Shares Spike: ETFs to TapNetflix Returns to Growth, Shares Spike: ETFs to Tap
ca.finance.yahoo.com - October 20 at 6:54 AM
Invesco Dynamic Media ETF declares quarterly distribution of $0.0773Invesco Dynamic Media ETF declares quarterly distribution of $0.0773
seekingalpha.com - September 20 at 11:04 PM
Disney Subscriber Base Overtakes Netflix: 5 ETFs to StreamDisney Subscriber Base Overtakes Netflix: 5 ETFs to Stream
finance.yahoo.com - August 11 at 4:00 PM
Communication Services ETFs Strengthen as Netflix Adopts Ad-Supported ServicesCommunication Services ETFs Strengthen as Netflix Adopts Ad-Supported Services
nasdaq.com - July 15 at 11:12 PM
Twitter Share Price Drops After Musk Tries to Renege on DealTwitter Share Price Drops After Musk Tries to Renege on Deal
nasdaq.com - July 11 at 8:36 PM
Media ETFs Climb on Buffett’s Berkshire Hathaway Paramount PositionMedia ETFs Climb on Buffett’s Berkshire Hathaway Paramount Position
finance.yahoo.com - May 21 at 9:26 PM
Musk’s Twitter Offer Isn’t Enough to Sway Social Media ETFsMusk’s Twitter Offer Isn’t Enough to Sway Social Media ETFs
nasdaq.com - April 14 at 10:56 PM
Which ETF will benefit most if Elon Musk buys Twitter?Which ETF will benefit most if Elon Musk buys Twitter?
seekingalpha.com - April 14 at 12:55 PM
Twitter’s Proposed Edit Feature Could Rewrite This ETF’s PathTwitter’s Proposed Edit Feature Could Rewrite This ETF’s Path
nasdaq.com - April 6 at 9:36 PM
Media, Communication Services ETFs Jump on Elon Musk’s Twitter HoldingsMedia, Communication Services ETFs Jump on Elon Musk’s Twitter Holdings
nasdaq.com - April 5 at 12:23 AM
Invesco Dynamic Media ETF declares quarterly distribution of $0.0758Invesco Dynamic Media ETF declares quarterly distribution of $0.0758
seekingalpha.com - March 23 at 11:55 PM
New Subscription Tier for Disney+ Should Impact Invesco FundsNew Subscription Tier for Disney+ Should Impact Invesco Funds
nasdaq.com - March 4 at 6:26 PM
Invesco Dynamic Media ETF (PBS)Invesco Dynamic Media ETF (PBS)
nasdaq.com - January 24 at 6:58 PM
Analysts Anticipate PBS Will Reach $64Analysts Anticipate PBS Will Reach $64
nasdaq.com - January 3 at 9:24 AM
QUAL, PBS: Big ETF OutflowsQUAL, PBS: Big ETF Outflows
nasdaq.com - December 10 at 12:54 PM

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

iCo Therapeutics logo

iCo Therapeutics

CVE:ICO
iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed drug candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.
Medifocus Inc. (MFS.V) logo

Medifocus Inc. (MFS.V)

CVE:MFS
Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.
Pascal Biosciences logo

Pascal Biosciences

CVE:PAS
Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.

Invesco Next Gen Media and Gaming ETF

NYSEARCA:PBS
PowerShares Dynamic Media Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Media Intellidex Index (the Index). The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States media companies. These are companies that are principally engaged in the development, production, sale and distribution of goods or services used in the media industry. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.